Moreover, Apatinib could reverse ABCB1- and ABCG2-mediated multidrug resistance in solid tumors as well as in leukemia cell lines [21, 22], thereby enhancing the efficacy of chemotherapeutic agents. The gene discussed is ABCB1; the disease is leukemia.